Jan Geliebter

18PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 15, 2026
Berberine Inhibits Eczematous Skin S. aureus-Induced Mast Cell/Basophil Activation and Modulates MAPK-Associated Gene Expression.

|Aug 27, 2026
Convergent Mechanistic Pathways Driving the Anaplastic Phenotype in Thyroid Cancer.

|Feb 13, 2026
Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Emerging Roles of Monoclonal Antibodies and Immune Modulation.

Stephanie Figueroa, Niradiz Reyes, Raj K Tiwari

|Jan 10, 2026
Ferroptosis-The "Double-Edged Sword" in Cancer: Mechanisms of Tumor Suppression/Resistance and Therapeutic Manipulation.

Danielle Quaranto, Nicole R DeSouza, Michelle Carnazza

|Dec 11, 2025
Long Non-Coding RNA DUXAP10 Promotes Tumorigenesis and Metastasis in Anaplastic Thyroid Cancer.

Nicole R DeSouza, Michelle Carnazza, Tara Jarboe

|Nov 26, 2025
A Small Molecule Compound, Berberine Reduces IgE but Not IgG Production via Promoting miRNA-34a-p53 Axis.

Michelle Carnazza, Madison Spears, Raj K Tiwari

Pageof 3

Frequent Collaborators

2 joint publications

Anish R Maskey

2 joint publications

Kate Nielsen

2 joint publications

Kaci Kopec

1 joint publications

Jeffry M Bulson